Case Business News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Case business. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Case Business Today - Breaking & Trending Today

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript

Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript February 1, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14. Quest Diagnostics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Quest Diagnostics Fourth […] ....

United States , New York , Paula Brown , Sam Samad , Jim Davis , Stewart Health Care , Alliance Foundation , Rutgers Cancer Institute , Trisalus Life Sciences , Revenues For Diagnostic Information Services , Journal Of Endocrine Society , Oncology Center , Quest Diagnostics , Endocrine Society , Trisalus Life , Diagnostic Information Services , Investor Relations , Haystack Oncology , Best Motorcycle Injury Lawyers , Revenue Growth , Case Business , Arnings Growth , Tim Davis , Fourth Quarter , Professional Lab Services ,

Life Science Giant Danaher Warns Of Sales Decline In 2024; Says 'Pandemic Has Transitioned To An Endemic State'

Tuesday, Danaher Corp (NYSE:DHR) reported a fourth-quarter 2023 adjusted EPS of $2.09, down from $2.54 a year ago, surpassing the consensus of $1.89. Sales decreased 10% Y/Y to $6.4 billion, beating the consensus of $6.09 billion. Non-GAAP core revenue decreased 11.5%, including a 4.5% non-GAAP base business core revenue decline. Operating cash flow was $1.6 billion, and non-GAAP free cash flow was $1.2 billion. Rainer Blair, President and Chief Executive Officer, stated, “We delivered better-th ....

Rainer Blair , Life Sciences , Danaher Corp , Chief Executive Officer , Goldman Sachs Downgrades Danaher , Says There , Shift Towards Pharmaceutical , Stock Market Game , Benzinga Pro , Day Trial , Revenue Decline , Operating Cash Flow , Revenue Growth , Free Cash Flow , Rainer Blair , Chief Executive Officer , Iotechnology Sales , Case Business ,